An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...
Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
High efficiency is key in applications such as data centers, and new standards codify the now-mandatory requirements.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Abstract: This paper presents a low-voltage pipelined-SAR ADC featuring a novel dynamic amplifier and inter-stage gain calibration scheme. The dynamic amplifier with cyclic operation achieves 16x gain ...
Abstract: This paper presents a timing-skew-free 12-bit 4-GS/s pipelined time-interleaved (TI)-SAR ADC that simultaneously achieves a high SFDR, a competitive SNDR, and superior power efficiency. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results